| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |